Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Plecanatide Improves Symptoms of Irritable Bowel Syndrome with Constipation: Results of an Integrated Efficacy and Safety Analysis of Two Phase 3 Trials.
Journal: International journal of general medicine
Published: March 21, 2023
Long-term safety of tenapanor in patients with irritable bowel syndrome with constipation in the T3MPO-3 study.
Journal: Neurogastroenterology and motility
Published: December 19, 2022
Filgotinib as induction and maintenance therapy for ulcerative colitis (SELECTION): a phase 2b/3 double-blind, randomised, placebo-controlled trial.
Journal: Lancet (London, England)
Published: December 18, 2020
Plecanatide Is Effective and Safe in the Treatment for Chronic Idiopathic Constipation: Results of a Phase II Trial.
Journal: Digestive diseases and sciences
Published: January 14, 2020
Effects of Apremilast, an Oral Inhibitor of Phosphodiesterase 4, in a Randomized Trial of Patients With Active Ulcerative Colitis.
Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Published: September 17, 2019
Efficacy, safety, and tolerability of plecanatide in patients with irritable bowel syndrome with constipation: results of two phase 3 randomized clinical trials.
Journal: The American journal of gastroenterology
Published: November 10, 2017
Corrigendum: Responsiveness of Endoscopic Indices of Disease Activity for Crohn's Disease.
Journal: The American journal of gastroenterology
Published: April 19, 2017
Epitope-specific immunotherapy targeting CD4-positive T cells in coeliac disease: two randomised, double-blind, placebo-controlled phase 1 studies.
Journal: The lancet. Gastroenterology & hepatology
Published: March 01, 2017
Responsiveness of Endoscopic Indices of Disease Activity for Crohn's Disease.
Journal: The American journal of gastroenterology
Published: July 05, 2016
Randomised clinical trial: a phase 1, dose-ranging study of the anti-matrix metalloproteinase-9 monoclonal antibody GS-5745 versus placebo for ulcerative colitis.
Journal: Alimentary pharmacology & therapeutics
Published: March 08, 2016
The small gastroenterology practice: how to survive in a changing world. Perspectives of a practicing clinician.
Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Published: December 16, 2014
Eluxadoline benefits patients with irritable bowel syndrome with diarrhea in a phase 2 study.
Journal: Gastroenterology
Published: October 09, 2012
Showing 1-12 of 12
Last Updated: 09/26/2026